1. Home
  2. PAYC vs BMRN Comparison

PAYC vs BMRN Comparison

Compare PAYC & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paycom Software Inc.

PAYC

Paycom Software Inc.

SELL

Current Price

$248.30

Market Cap

11.8B

Sector

Technology

ML Signal

SELL

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

SELL

Current Price

$58.42

Market Cap

12.3B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PAYC
BMRN
Founded
1998
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8B
12.3B
IPO Year
2014
1999

Fundamental Metrics

Financial Performance
Metric
PAYC
BMRN
Price
$248.30
$58.42
Analyst Decision
Hold
Buy
Analyst Count
21
28
Target Price
★ $271.00
$90.19
AVG Volume (30 Days)
659.3K
★ 2.2M
Earning Date
11-04-2026
11-02-2026
Dividend Yield
★ 0.61%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 8.40
0.14
Revenue
$433,047,000.00
★ $1,313,646,000.00
Revenue This Year
$7.98
$20.05
Revenue Next Year
$7.59
$14.91
P/E Ratio
★ $30.35
$414.29
Revenue Growth
N/A
★ 17.62
52 Week Low
$104.90
$49.26
52 Week High
$275.22
$70.98

Technical Indicators

Market Signals
Indicator
PAYC
BMRN
Relative Strength Index (RSI) 50.73 53.64
Support Level $213.03 $58.03
Resistance Level $274.15 $58.39
Average True Range (ATR) 9.75 1.86
MACD -1.85 0.33
Stochastic Oscillator 43.94 81.89

Price Performance

Historical Comparison
PAYC
BMRN

About PAYC Paycom Software Inc.

Paycom is a cloud-based human capital management provider offering payroll, compliance, and human resources management solutions. The firm's solutions are available on a unified, modular platform, and customers are billed for access on a subscription basis. Paycom's customer base skews toward the midmarket and is primarily based in North America. As of 2025, the firm manages records for 7.4 million employees across more than 20,000 clients on a parent-company-group basis.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: